🕒 Created · Updated

Chris Wright notes potential lack of formal nuclear agreement with Iran as European stocks dip

European stock markets traded lower on Tuesday as investors reacted to rising oil prices and ongoing tensions in the Middle East. The pan-European Stoxx 600 benchmark fell approximately 0.6% as Germany's DAX, London's FTSE 100, and France's CAC 40 all recorded losses. Energy shares rose as Brent crude futures climbed toward $98.50 per barrel, driven by concerns that the conflict between the U.S. and Iran could disrupt global supplies. U.S. Secretary of Energy Chris Wright stated that a formal nuclear agreement with Iran may not happen anytime soon. Wright noted that the U.S. might instead focus on destroying Iran's capabilities to develop a nuclear weapon. President Trump has consistently identified preventing Iran from acquiring a nuclear weapon as a primary objective of the U.S. campaign. In the pharmaceutical sector, Novartis saw significant share price declines following two consecutive drug development setbacks. The company reported that its experimental cholesterol drug, pelacarsen, failed to reduce cardiovascular risk in a late-stage trial. Additionally, the company announced that its del-desiran drug for myotonic dystrophy failed to meet its primary endpoint in late-stage testing.

Sources

Paywall and unreadable sources